This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Institut Jean Paoli & Irène Calmettes, National Institute of Health and Medical Research. Active years: 2019.
Company Filing History:
1 out of 5,383 
1 out of 32 
1 out of 1,853 
Years Active: 2019
Title: Marc Turini: Innovator in Cancer Treatment
Introduction
Marc Turini is a notable inventor based in Marseille, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic antibodies.
Latest Patents
One of his key patents is titled "Anti-HER2 single domain antibodies, polypeptides comprising thereof and their use for treating cancer." This invention focuses on the development of anti-HER2 single domain antibodies and their application in cancer therapy. The patent highlights the potential of these polypeptides in targeting and treating HER2-positive cancers.
Career Highlights
Throughout his career, Marc Turini has worked with esteemed institutions such as the National Institute of Health and Medical Research and the Institut Jean Paoli & Irène Calmettes. His work in these organizations has been pivotal in advancing cancer research and treatment methodologies.
Collaborations
Marc has collaborated with notable professionals in his field, including Patrick Chames and Brigitte Kerfelec. These partnerships have contributed to the success of his research and the development of innovative cancer therapies.
Conclusion
Marc Turini's contributions to cancer treatment through his patented inventions and collaborations with leading researchers underscore his importance in the field of medical innovation. His work continues to inspire advancements in therapeutic approaches for cancer patients.